EPO and Global developmental delay: However, advances such as avoidance of aluminium (which led to aluminium-induced neurotoxicity secondary to CKD treatment), improved nutrition, improved anemia control (with erythropoietin), have significantly decrease the prevalence of developmental delay in CKD.